# Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

> **NCT00083954** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 530 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Quetiapine Fumarate

## Key facts

- **NCT ID:** NCT00083954
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 530 (—)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083954, "Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00083954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*